Category Archives: Stell Cell Research


Global Stem Cell Media Market |2018-2023| Qualitative & Quantitative Analysis, Key Vendors Analysis, Reliability, Growth Innovation in Technology…

!!Big Bash Offers for All Reports on This Christmas & New Year Season!!

Christmas Is Doing A Little Something Extra For Someone. Get FLAT 25 % Discount On All Research Reports.

Be the Santa of Your Happy Business!

The Global Stem Cell Media Market report highlights the most recent market trends. Stem Cell Media report unveils vulnerabilities that may emerge because of changes in business activities or presentation of another item in this report. It is designed in such a way that it provides an evident understanding of an industry. This Stem Cell Media market report is comprised of the combination of best industry insight, practical explanation and talent solutions. It explains research of the existing scenario of the global market, which takes into consideration numerous market dynamics. Stem Cell Media report also perceives the different drivers and limitations affecting the market amid the estimate time frame.

Stem Cell Media Market Segmentation By Type, Applications & Regions

Request For Free Sample PDF Report @ https://www.globalmarketers.biz/report/life-sciences/2018-global-stem-cell-media-industry-research-report/117851 #request_sample

The global Stem Cell Media market was valued at $XX million in 2018, and analysts expect the global market size will touch $XX million by the end of 2023, growing at a CAGR of XX% between 2019 and 2023. This report runs detailed bygone analysis of global market for Stem Cell Media from 2013-2018, and offers widespread market forecasts from 2019-2023 by regions and subsectors. It covers the sales size, price, revenue, gross margin, ancient growth and future perspectives in the Stem Cell Media market.

Grab FLAT 25% Off On All Our Syndicated Research Reports.

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction to the Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also included]

The Stem Cell Media market report offers key statistics information on the market situation of the Stem Cell Media Stem Cell Media companies and person involved in the industry. A Stem Cell Media Market serves an exhaustive view of size, trends and aspect have been included in this report to analyze factors that will perform a significant impact in propelling the sales of Stem Cell Media Market in the upcoming years.

A chapter-wise format in the form of numbers, graphical representations are given. The Stem Cell Media leading companies all around the world are recognized to help in-process state and direction of the business. In addition, complete Stem Cell Media information of these manufacturers and their market share by various regions, with the company and product introduction. The Stem Cell Media is a crucial source for each market segment, speculator, and other players.

Have You Any Queries ask to Our Expert OR Request a custom study: https://www.globalmarketers.biz/report/life-sciences/2018-global-stem-cell-media-industry-research-report/117851 #inquiry_before_buying

Key Highlights points of Stem Cell Media Market 2019:

Competitive study of the major Stem Cell Media market players will help in analyzing the market driving and business strategies.

Analysis of necessary trends impacting to the build-up of the market.

The deep research study of market-based development possibilities, growth limiting factors and feasibility of investment will forecast the market growth.

Analysis of trending factors will be influencing the Market shares in the next few years.

The forecast extent for geographical divisions (regions), as well as sub-areas, will develop at the most elevated rate.

An overview of the global market for Global,Stem Cell Media Market and related technologies.

Instantly Get Whole Report Access, Purchase Report @

In conclusion, it is a deep research report on Global Stem Cell Media industry. This Stem Cell Media market report covers all the aspects of market vendors, product, its multiple applications, offer clients the scope to classify feasible market possibilities to expand markets. In addition to this, the trends and revenue analysis of the global Stem Cell Media market has been mentioned in this report.

Customization Service of the Report:

Global Marketers.biz provides customization of reports as per your need. The report can be altered to meet your requirements. Contact our sales team, who will guarantee you to get a report that suits your needs.

Please get in touch with our sales squad (Alex@globalmarketers.biz).

For more relevant information visit @https://www.globalmarketers.biz/

Browse Table Of content @: https://www.globalmarketers.biz/report/life-sciences/2018-global-stem-cell-media-industry-research-report/117851 #table_of_contents

!!!!****Big Bash Offers For All Reports on This Christmas Season****!!!!

Hurry Up!!!! Get Flat 25 % Discount Uptill 31st Of December

See the article here:
Global Stem Cell Media Market |2018-2023| Qualitative & Quantitative Analysis, Key Vendors Analysis, Reliability, Growth Innovation in Technology...

Global Stem Cell Therapy Market to Become a Worth US$ 4759.27 Million By 2024 – E-Industry News

The Global Stem Cell Therapy Market Set For Rapid Growth, To Reach Around USD 4759.27 Million By 2024Research Report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.The global Stem Cell Therapy Market report is a systematic study of the globalStem Cell Therapy Marketintroducing the advanced state of affairs in the market as well as schemes that aid in its enlargement in the coming years. The report evaluates several factors determining the market expansion as well as the volume of the whole Stem Cell Therapy Market. The report states the aggressive vendor scenery of the market together with the profiles of some of the leading market players. The most important players in the Stem Cell Therapy Market are also discussed in the report.

This Research will help you grow your Business: [Download free Sample PDF of This Research Report]

Some of the Major Stem Cell Therapy Market Players Are:

The report covers the product contributions, revenue generated, segmentation, and business summarization of the foremost players. The report provides data taking into consideration the latest improvements in the global Stem Cell Therapy Market while estimating the contribution in the market of the most important players in the near future. The report estimates the limitation and power of the leading players via SWOT analysis and assesses their growth in the market. Additionally, the key product categories and segments as well as the sub-segments of the global market are clarified in the report.

The market assessment is also estimated throughout the research as well as concludes the data using Porters five analysis on the market enlargement.Further, the report also scrutinizes the Stem Cell Therapy Market based on the manufactured goods categories and customer segments as well as the development of each segment is calculated over the predicted time.

Request Free research report Brochure @https://www.zionmarketresearch.com/requestbrochure/stem-cell-therapy-market

The report collects information accumulated from various authoritarian organizations to estimate the growth of the segments. Additionally, the study also evaluates the global Stem Cell Therapy Market on the basis of the topography and analyzes the macro- and microeconomic features determining the market expansion in every area. Furthermore, the Stem Cell Therapy Market is classified on the basis of various regions.

The Stem Cell Therapy Market segmented by regions/countries:

Browse Press Release:https://www.zionmarketresearch.com/news/stem-cell-therapy-market

Highlights of Stem Cell Therapy Market Report:

1) Global Stem Cell Therapy Market share & sales assessments on the basis of regional and country level segments.

2) Industry share analysis of the top market players.

3) Strategic recommendations for the new companies.

4) Market forecasts for 5 years of all the mentioned segments, sub segments and the regional markets.

5) Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations).

6) Competitive landscaping mapping the key trends.

7) Company profiles with their strategies, financials, and recent developments.

8) Production Supply chain trends analysis latest technological advancements.

Inquire more about this report @https://www.zionmarketresearch.com/inquiry/stem-cell-therapy-market

Objective of Studies:

1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Stem Cell Therapy Market.

2. To provide insights about factors affecting the market growth. To analyse the Stem Cell Therapy Market based on various factors- price analysis, supply chain analysis, Porte five force analysis etc.

3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, Latin America and Rest of the World.

4. To provide country level analysis of the market with respect to the current market size and future prospective.

5. To provide country level analysis of the market for segment by application, product type and sub-segments.

6. To provide strategic profiling of key players in the market, comprehensively analysing their core competencies, and drawing a competitive landscape for the market.

7. To track and analyse competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Stem Cell Therapy Market.

Why Trust ZMRs Analytical Insights?

Target Audience of Stem Cell Therapy Market:

Manufacturer / Potential Investors

Traders, Distributors, Wholesalers, Retailers, Importers and Exporters

Association and government bodies

Also, Research Report Examines:

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

More:
Global Stem Cell Therapy Market to Become a Worth US$ 4759.27 Million By 2024 - E-Industry News

Stem Cell Market to 2025 Analysis by Top Vendors – Space Market Research

OG Analysis, a global market research firm, has announced the release of their Stem Cell market outlook to 2025 report includes the latest predictions of global Stem Cell market along with geography, therapy area and applications. The report specifically focuses on different types of Stem Cell with a special attention of their emergence over the forecast period to 2025.

Browse Stem Cell Market Research Report https://www.oganalysis.com/industry-reports/217751/stem-cell-market

The research report provides objective measures to tap into the future opportunities that will be available over the next six years. It also highlights key areas to watch over the future along with detailed insights into drivers and challenges across different Stem Cell applications and products.

The Stem Cell market report aggregates the current market size based on volume and average price data. It also includes six year outlook to 2025 on the basis of anticipated growth rates for each sub segment and industry as a whole.

The base case outlook in the next six years for different types of Stem Cell, across different verticals and countries is provided. It additionally examines the key dynamics around companies, markets, along with key trends, drivers and challenges facing the Stem Cell worldwide.

Request Sample @ https://www.oganalysis.com/sample/217751

The report covers a broad region from Asia Pacific, North America, Europe, Latin America and Middle East Africa for the period of 2018 to 2025. 12 countries across these regions are analyzed independently in the Stem Cell report. Impact of domestic market conditions, price variations, competition, government policies, healthcare spending, technological and local market conditions are assessed for country level forecasts.

Global spending on healthcare continues to increase significantly with ageing population, increased access to treatment and ongoing advancements in technology. This provides strong support for Stem Cell market growth in the medium to long term future. While growth will remain steady in the developed markets, Asian and other emerging markets will be key for Stem Cell market growth from 2019 to 2025.

Request for Special Discount on Stem Cell Market report @ https://www.oganalysis.com/discount/217751

To address the expanding need for advanced Stem Cell products, companies are rapidly embracing the new market dynamics, primarily focusing on new launches, specifically to suit local and regional demand patterns. Accordingly, detailed discussion about broader implications of key strategies, product launches and other latest Stem Cell market developments are included in the research work.

About OG Analysis:

OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions.

Contact Us:

Ambarish

Phone: +1 860 777 1418, +91-7337 01 3757

Email: [emailprotected]

Website: https://www.oganalysis.com

Follow Us on LinkedIn: https://www.linkedin.com/company/og-analysis/

This post was originally published on Space Market Research

More here:
Stem Cell Market to 2025 Analysis by Top Vendors - Space Market Research

Harvard geneticist George Church’s goal: to protect humans from viruses, genetic diseases, and aging – 60 Minutes – CBS News

Our lives have been transformed by the information age. But what's coming next is likely to be more profound, call it the genetic information age. We have mapped the human genome and in just the last few years we have learned to read and write DNA like software. And you're about to see a few breakthroughs-in-waiting that would transform human health. For a preview of this revolution in evolution we met George Church, a world leading geneticist, whose own DNA harbors many eccentricities and a few genes for genius.

We found George Church in here.

Cory Smith: Most of these are frozen George. Little bits of George that we have edited all in different tubes.

Church threw himself into his work, literally. His DNA is in many of the experiments in his lab at Harvard Medical School. The fully assembled George Church is 6'5" and 65. He helped pioneer mapping the human genome and editing DNA. Today, his lab is working to make humans immune to all viruses, eliminate genetic diseases, and reverse the effects of time.

Scott Pelley: One of the things your lab is working on is reversing aging.

George Church: That's right.

Scott Pelley: How is that possible?

George Church: Reversing aging is one of these things that is easy to dismiss to say either we don't need it or is impossible or both.

Scott Pelley: Oh, we need it.

George Church: Okay. We need it. That's good. We can agree on that. Well, aging reversal is something that's been proven about eight different ways in animals where you can get, you know, faster reaction times or, you know, cognitive or repair of damaged tissues.

Scott Pelley: Proven eight different ways. Why isn't this available?

George Church: It is available to mice.

In lucky mice, Church's lab added multiple genes that improved heart and kidney function and levels of blood sugar. Now he's trying it in spaniels.

Scott Pelley: So is this gene editing to achieve age reversal?

George Church: This is adding genes. So, it's not really editing genes. It's, the gene function is going down, and so we're boosting it back up by putting in extra copies of the genes.

Scott Pelley: What's the time horizon on age reversal in humans?

George Church: That's in clinical trials right now in dogs. And so, that veterinary product might be a couple years away and then that takes another ten years to get through the human clinical trials.

Human trials of a personal kind made George Church an unlikely candidate to alter human evolution. Growing up in Florida, Church was dyslexic, with attention deficit, and frequently knocked out by narcolepsy.

Scott Pelley: What was it that made you imagine that you could be a scientist?

George Church: The thing that got me hooked was probably the New York World's Fair in 1964. I thought this is the way we should all be living. When I went back to Florida, I said, "I've been robbed," you know? "Where is it all?" So, I said, "Well, if they're not going to provide it, then I'm gonna provide it for myself."

With work and repetition, he beat his disabilities and developed a genius for crystallography, a daunting technique that renders 3D images of molecules through X-rays and math. But in graduate school at Duke, at the age of 20, his mania for the basic structures of life didn't leave time for the basic structure of life.

Scott Pelley: You were homeless for a time.

George Church: Yeah. Briefly.

Scott Pelley: Six months.

George Church: Six months.

Scott Pelley: And where were you sleeping when you were homeless?

George Church: Well, yeah. I wasn't sleeping that much. I was mostly working. I'm narcoleptic. So, I fall asleep sitting up anyway.

His devotion to crystallography was his undoing at Duke.

George Church: I was extremely excited about the research I was doing. And so, I would put in 100-plus hours a week on research and then pretty much didn't do anything else.

Scott Pelley: Not go to class.

George Church: I wouldn't go to class. Yeah.

Duke kicked him out with this letter wishing him well in a field other than biology. But, it turned out, Harvard needed a crystallographer. George Church has been here nearly 40 years. He employs around 100 scientists, about half-and-half men and women.

Scott Pelley: Who do you hire?

George Church: I hire people that are self-selecting, they see our beacon from a distance away. There are a lot of people that are a little, you know, might be considered a little odd. "Neuroatypicals," some of us are called.

Scott Pelley: "Neuroatypical?"

George Church: Right.

Scott Pelley: Unusual brains?

George Church: Right, yeah.

Parastoo Khoshakhlagh: One thing about George that is very significant is that he sees what you can't even see in yourself.

Parastoo Khoshakhlagh and Alex Ng are among the "neuroatypicals." They're engineering human organ tissue.

Cory Smith: I think he tries to promote no fear of failure. The only fear is not to try at all.

Cory Smith's project sped up DNA editing from altering three genes at a time to 13,000 at a time. Eriona Hysolli went to Siberia with Church to extract DNA from the bones of wooly mammoths. She's editing the genes into elephant DNA to bring the mammoth back from extinction.

Eriona Hysolli: We are laying the foundations, perhaps, of de-extinction projects to come.

Scott Pelley: De-extinction.

Eriona Hysolli: Yes.

Scott Pelley: I'm not sure that's a word in the dictionary yet.

Eriona Hysolli: Well, if it isn't, it should be.

Scott Pelley: You know there are people watching this interview who think that is playing God.

George Church: Well, it's playing engineer. I mean, humans have been playing engineer since the dawn of time.

Scott Pelley: The point is, some people believe that you're mucking about in things that shouldn't be disturbed.

George Church: I completely agree that we need to be very cautious. And the more powerful, or the more rapidly-moving the technology, the more cautious we need to be, the bigger the conversation involving lots of different disciplines, religion, ethics, government, art, and so forth. And to see what it's unintended consequences might be.

Church anticipates consequences with a full time ethicist in the lab and he spends a good deal of time thinking about genetic equity. Believing that genetic technology must be available to all, not just those who can afford it.

We saw one of those technologies in the hands of Alex Ng and Parastoo Khoshakhlagh. They showed us what they call "mini-brains," tiny dots with millions of cells each. They've proven that cells from a patient can be grown into any organ tissue, in a matter of days, so drugs can be tested on that patient's unique genome.

Scott Pelley: You said that you got these cells from George's skin? How does that work?

Alex Ng: We have a way to reprogram essentially, skin cells, back into a stem cell state. And we have technologies where now we can differentiate them into tissue such as brain tissue.

Scott Pelley: So you went from George's skin cells, turned those into stem cells, and turned those into brain cells.

Alex Ng: Exactly. Exactly.

Scott Pelley: Simple as that.

Organs grown from a patient's own cells would eliminate the problem of rejection. Their goal is to prove the concept by growing full sized organs from Church's DNA.

George Church: It's considered more ethical for students to do experiments on their boss than vice versa and it's good to do it on me rather than some stranger because I'm as up to speed as you can be on the on the risks and the benefits. I'm properly consented. And I'm unlikely to change my mind.

Alex Ng: We have a joke in the lab, I mean, at some point, soon probably, we're going to have more of his cells outside of his body than he has himself.

Church's DNA is also used in experiments designed to make humans immune to all viruses.

George Church: We have a strategy by which we can make any cell or any organism resistant to all viruses by changing the genetic code. So if you change that code enough you now get something that is resistant to all viruses including viruses you never characterized before.

Scott Pelley: Because the viruses don't recognize it anymore?

George Church: They expect a certain code provided by the host that they replicate in. the virus would have to change so many parts of its DNA or RNA so that it can't change them all at once. So, it's not only dead. But it can't mutate to a new place where it could survive in a new host.

Yes, he's talking about the cure for the common cold and the end of waiting for organ transplants. It's long been known that pig organs could function in humans. Pig heart valves are routinely transplanted already. But pig viruses have kept surgeons from transplanting whole organs. Church's lab altered pig DNA and knocked out 62 pig viruses.

Scott Pelley: What organs might be transplanted from a pig to a human?

George Church: Heart, lung, kidney, liver, intestines, various parts of the eye, skin. All these things.

Scott Pelley: What's the time horizon on transplanting pig organs into human beings?

George Church: you know, two to five years to get into clinical trials. And then again it could take ten years to get through the clinical trials.

Church is a role model for the next generation. He has co-founded more than 35 startups. Recently, investors put $100 million into the pig organ work. Another Church startup is a dating app that compares DNA and screens out matches that would result in a child with an inherited disease.

George Church: You wouldn't find out who you're not compatible with. You'll just find out who you are compatible with.

Scott Pelley: You're suggesting that if everyone has their genome sequenced and the correct matches are made, that all of these diseases could be eliminated?

George Church: Right. It's 7,000 diseases. It's about 5% of the population. It's about a trillion dollars a year, worldwide.

Church sees one of his own genetic differences as an advantage. Narcolepsy lulls him several times a day. But he wakes, still in the conversation, often, discovering inspiration in his twilight zone.

Scott Pelley: If somebody had sequenced your genome some years ago, you might not have made the grade in some way.

George Church: I mean, that's true. I would hope that society sees the benefit of diversity not just ancestral diversity, but in our abilities. There's no perfect person.

Despite imperfection, Church has co-authored 527 scientific papers and holds more than 50 patents. Proof that great minds do not think alike.

The best science can tell, it was about 4 billion years ago that self-replicating molecules set off the spark of biology. Now, humans hold the tools of evolution, but George Church remains in awe of the original mystery: how chemistry became life.

Scott Pelley: Is the most amazing thing about life, then, that it happened at all?

George Church: It is amazing in our current state of ignorance. We don't even know if it ever happened ever in the rest of the universe. it's awe-inspiring to know that it either happened billions of times, or it never happened. Both of those are mind boggling. It's amazing that you can have such complex structures that make copies of themselves. But it's very hard to do that with machines that we've built. So, we're engineers. But we're rather poor engineers compared to the pseudo engineering that is biological evolution.

Produced by Henry Schuster. Associate producer, Rachael Morehouse. Broadcast associate, Ian Flickinger.

Read more from the original source:
Harvard geneticist George Church's goal: to protect humans from viruses, genetic diseases, and aging - 60 Minutes - CBS News

Start-up to research on degenerative eye disease – Deccan Herald

A city-based medical science startup is gearing up to halt the progress of degenerative eye disease in Indians after trials in blind rats showed the creatures regaining their sight in a few months.

Age-Related Macular Degeneration (AMD) is a form of blindness that affects a segment of the adult population after they reach the age of 50. It accounts for 8.7% of all blindness worldwide. Retinitis Pigmentosa (RP), meanwhile, is a rare genetic disorder, which affects one child in 4,000.

There is no known cure for the diseases. However, Dr Jogin Desai, whose startup, Eyestem, which has been under incubation by the governments Centre for Cellular and Molecular Platforms (C-Camp) for the past three years, believes its work can halt the progression of the diseases by using genetically modified stem cells to restore the pigment epithelium in the cornea.

The pigment epithelium, which is only 1.5 mm thick, performs critical functions that support photoreceptor health and integrity. It was likened to the foundation of a building. The therapy will also seek to restore the photoreceptor cells in the retina, which were likened to buildings. Phase 1 human clinical trials are set to start within two-and-half months.

Existing research postulates that using biodegradable scaffolding upon which modified cells are stacked can help rebuild the pigment epithelium. However, Dr Desai said that current work delivering modified Eycyte-RPE (or Retinal Pigment Epithelium) cells, which are suspended in the liquid, is even more effective.

We have found that cells delivered in this way automatically seek out their body niche and assimilate into the system, he said, adding that trials in blind lab rats had showed the animals regaining their vision over a two-month period.

Most discoveries fail

Desai, however, cautioned that no amount of promise can legitimise an idea if its time has not yet come. In fact, just one of 1,600 scientific discoveries made in research labs makes it into a fully fledged development where it can impact peoples lives, he explained.

Most scientific discoveries are weeded out in exacting, three-phased clinical trials, based on the criteria of safety, scalability and effectiveness.

See original here:
Start-up to research on degenerative eye disease - Deccan Herald

R&D Activities to Fast-track the Growth of the Stem Cell Assay Market Between 2018 2028 – Kentucky Reports

TMRR, in its latest market intelligence study, finds that the global Stem Cell Assay market registered a value of ~US$ xx Mn/Bn in 2018 and is spectated to grow at CAGR of xx% during the foreseeable period 2019-2029. In terms of product type, segment holds the largest share, while segment 1 and segment 2 hold significant share in terms of end use.

The Stem Cell Assay market study outlines the key regions Region 1 (Country 1, Country 2), region 2 (Country 1, Country 2), region 3 (Country 1, Country 2) and region 4 (Country 1, Country 2). All the consumption trends and adoption patterns of the Stem Cell Assay are covered in the report. Prominent players, including player 1, player 2, player 3 and player 4, among others, account for substantial shares in the global Stem Cell Assay market.

Limited discount offer!!! Purchase reports before the offer ends!!!

Request For Discount On This Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=40&source=atm

growth drivers and lists down the major restraints. Additionally, the report gauges the effect of Porters five forces on the overall stem cell assay market.

Global Stem Cell Assay Market: Key Market Segments

For the purpose of the study, the report segments the global stem cell assay market based on various parameters. For instance, in terms of assay type, the market can be segmented into isolation and purification, viability, cell identification, differentiation, proliferation, apoptosis, and function. By kit, the market can be bifurcated into human embryonic stem cell kits and adult stem cell kits. Based on instruments, flow cytometer, cell imaging systems, automated cell counter, and micro electrode arrays could be the key market segments.

In terms of application, the market can be segmented into drug discovery and development, clinical research, and regenerative medicine and therapy. The growth witnessed across the aforementioned application segments will be influenced by the increasing incidence of chronic ailments which will translate into the rising demand for regenerative medicines. Finally, based on end users, research institutes and industry research constitute the key market segments.

The report includes a detailed assessment of the various factors influencing the markets expansion across its key segments. The ones holding the most lucrative prospects are analyzed, and the factors restraining its trajectory across key segments are also discussed at length.

Global Stem Cell Assay Market: Regional Analysis

Regionally, the market is expected to witness heightened demand in the developed countries across Europe and North America. The increasing incidence of chronic ailments and the subsequently expanding patient population are the chief drivers of the stem cell assay market in North America. Besides this, the market is also expected to witness lucrative opportunities in Asia Pacific and Rest of the World.

Global Stem Cell Assay Market: Vendor Landscape

A major inclusion in the report is the detailed assessment of the markets vendor landscape. For the purpose of the study the report therefore profiles some of the leading players having influence on the overall market dynamics. It also conducts SWOT analysis to study the strengths and weaknesses of the companies profiled and identify threats and opportunities that these enterprises are forecast to witness over the course of the reports forecast period.

Some of the most prominent enterprises operating in the global stem cell assay market are Bio-Rad Laboratories, Inc (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.K.), Hemogenix Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), STEMCELL Technologies Inc. (CA), Cell Biolabs, Inc. (U.S.), and Cellular Dynamics International, Inc. (U.S.).

Request Sample Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=40&source=atm

The Stem Cell Assay market research answers important questions, including the following:

The Stem Cell Assay market research serves a platter of the following information:

Customize This Report @ https://www.tmrresearch.com/sample/sample?flag=CR&rep_id=40&source=atm

Why go for TMRR?

TMRR stays aligned with the fact the organization lands among the leading market research firms in India. Our analysts work irrespective of the time-zone, the result, we are being recognized worldwide. We abide by the notion that each client has his/her own set of requirements. With extensive primary and secondary research, our experts churn out the most accurate information regarding the desired the market.

Read the rest here:
R&D Activities to Fast-track the Growth of the Stem Cell Assay Market Between 2018 2028 - Kentucky Reports

The Making of a Root – Duke Today

DURHAM, N.C. -- When most people think of a plant, they picture stems, leaves, flowers, and all the parts that are visible above ground. But Duke biologist Philip Benfey is more interested in the hidden half of the plant that is buried beneath the soil. Roots: they may be out of sight, Benfey says, but they play critical roles, anchoring the plant and taking up water and nutrients.

Now, Benfey and colleagues Masashi Yamada and Xinwei Han have pieced together new details in the cascade of events that guide root growth -- research that could lead to more productive crops optimized for different soil types.

As a root tunnels through the soil, stem cells in the roots tip must determine whether to divide and producemore of the same stem cells, or differentiate into other cell types, based on their location within the root tissue. In a study published in the journal Nature, the researchers show that cells get some of the information they need from substances that are usually thought to be harmful.

Natural byproducts of cellular respiration, molecules called reactive oxygen species have long been described as stress signals that can cause tissue damage if left unchecked. But they also play a role in cell signaling, Benfeys work shows.

In a study of the small flowering plant Arabidopsis thaliana, the researchers report that root growth is partly regulated by interactions between two types of reactive oxygen species, superoxide and hydrogen peroxide, as they build up in different regions of the root tip.

What we did was map out, from signal to response, how these supposedly toxic chemicals are harnessed for a signaling process, Benfey said.

Roots grow longer thanks to a small region of stem cells at the end of each root that produces a constant supply of new cells behind it, propelling the root tip further downward through the soil like the head of a bullet. The daughter cells that are left behind stay put, and eventually stop dividing and start to specialize.

How fast a root grows depends on the balance between two opposing cues: those that encourage these stem cells to keep multiplying, and those that tell them to put the brakes on proliferating and change gears to specialize. The researchers identified a protein called RITF1 that, when activated, triggers this developmental switch.

The protein works by controlling where the two reactive oxygen species concentrate within the growing tip of the root.

These chemical signals tell the surrounding cells what course of action to take next. Cells exposed to higher amounts of superoxide keep dividing and producing new cells, while those that get a heavy dose of hydrogen peroxide differentiate, with a zone of transition where the two overlap.

We dont have all the pieces yet, Benfey said, but there are a lot more steps of the process that are now known through this work than were known before.

Reactive oxygen species arent just toxic chemicals, Benfey said. They serve important roles as regulators of a developmental process, going from a stem cell to fully differentiated tissue.

This research was supported by the Howard Hughes Medical Institute, the Gordon and Betty Moore Foundation (GBMF3405), and the U.S. National Institutes of Health (MIRA 1R35GM131725).

CITATION: "RGF1 Controls Root Meristem Size Through ROS Signalling," Masashi Yamada, Xinwei Han, Philip N. Benfey. Nature, December 4, 2019. DOI: 10.1038/s41586-019-1819-6

Read this article:
The Making of a Root - Duke Today

Engelhardt named 2019 Fellow of the National Academy of Inventors – Iowa Now

The National Academy of Inventors (NAI) has named University of Iowa cystic fibrosis and gene therapy researcher John Engelhardt, PhD, a 2019 Fellow.

Engelhardt, who is professor and head of anatomy and cell biology in the UI Carver College of Medicine and director of the UI Center for Gene Therapy, is recognized for his work in developing gene therapies to treat cystic fibrosis (CF). He will receive the award during an induction ceremony at the Heard Museum in Phoenix, Arizona, on April 10, 2020.

Engelhardts research primarily focuses on the molecular basis of CF, a progressive, inherited disease that causes persistent lung infections and other complications. CF is caused by well-studied mutations in a single gene, and Engelhardt has worked to develop gene therapy and gene editing methods to help treat the condition.

He also develops viral vector systems and animal models to test these methods and ultimately improve gene delivery. The animal models his laboratory has created are used by over 80 CF researchers, and he recently renewed a Research and Resource Center, funded by the National Institutes of Health (NIH), to continue this service to the research community and biotechnology companies that are developing therapies for CF and other lung diseases.

Engelhardt additionally studies airway stem cell niches, or the regulatory mechanisms that control stem cell growth and repair in the lungs, and has developed stem cell therapies for CF.

He currently holds 12 issued US patents, 41 issued foreign patents, and has 23 active patent applications. His patents and applications have been licensed to six companies, including two start-ups and a Fortune 100 company. Engelhardt provides critical tools and assistance to other researchers and companies in the field of CF research, and he is sponsored by the Cystic Fibrosis Foundation.

Engelhardt co-founded the gene therapy company Talee Bio, which was sold and is now Spirovant Sciences. The Philadelphia-based company was recently a part of a $3 billion deal to enhance the development of gene therapies for CF and other genetic diseases. Engelhardt remains on the scientific advisory board for Spirovant Sciences and serves as a key advisor as new therapies are created and tested.

NAI President Paul Sanberg says Engelhardt was selected for induction as he has demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development, and welfare of society.

The University of Iowa Research Foundation (UIRF) nominated Engelhardt for this award to recognize his impact on creating and broadly commercializing gene therapies and his mentoring of other entrepreneurs on campus.

John has an extensive portfolio of intellectual property for advancing the commercialization of gene therapies, said Marie Kerbeshian, executive director of UIRF and an assistant vice president in the Office of the Vice President for Research. Not only is he a successful entrepreneur, as a UI researcher he is a key supporter of other researchers and other companies as they seek cures for cystic fibrosis.

He is one of 168 distinguished academic inventors across 136 research universities and institutes worldwide to join the academy this year. To date, NAI Fellows hold more than 41,500 issued U.S. patents, and the 2019 class includes six recipients of the U.S. National Medal of Technology & Innovation and U.S. National Medal of Science, four Nobel Laureates, among other honors.

We are very proud to see Dr. Engelhardts innovative and groundbreaking work recognized nationally, said Brooks Jackson, MD, MBA, UI vice president for medical affairs and the Tyrone D. Artz Dean of the UI Carver College of Medicine. He is a pioneer in his field and has set a prime example of how dedication and collaboration can lead to major advances in finding treatments for debilitating diseases.

Engelhardt is the second UI faculty member to join the academy, after UI neurosurgeon Matthew Howard, MD, was named a 2018 fellow for his work in developing brain and spinal cord neuromodulation devices.

Engelhardt joined the UI faculty in 1997 and is the Roy J. Carver Chair in Molecular Medicine and director of the Center for Gene Therapy of Cystic Fibrosis, which has received funding from the NIH continuously over the past 20 years. He earned a doctoral degree in human genetics from Johns Hopkins University and was a post-doctoral fellow at the University of Michigan. He has published 263 articles and book chapters, and has received over $74 million dollars in NIH grant support for his research.

Link:
Engelhardt named 2019 Fellow of the National Academy of Inventors - Iowa Now

In the Spotlight: ‘When you’re in a minority group, you’re never just a grad student’ – Scope

No day is the same for Carolyn Dundes, a PhD candidate in the Stem Cell Biology and Regenerative Medicine program and an LGBTQ community advocate. That's just the way Dundes likes it.

Dundes spoke with me aboutresearch, activism outside the lab and the importance of "finding your community."

Where were you before you came to Stanford?

I did my undergraduate degree at Wesleyan University. I loved it there. I did a lot of research in the lab of ProfessorLaura Grabel, PhD, studying the signals that regulate embryonic brain development.

What got you interested in that field?

Science is something I've always been super interested in, particularly the mystery of how the brain develops. I remember thinking, "How have people not figured this out yet?" Turns out it's really hard, that's why!

My first research experience was at the University of Connecticut. We were studying a really cool -- to the extent that you can say any disease is cool -- epigenetically-inherited disease called Prader-Willi Syndrome. Depending on whether the genetic error is passed down on the maternal or paternal copy of the chromosome, the observable characteristics of the disease -- known as the phenotype -- are different.

The lab was super welcoming and they patiently answered all of my endless questions. From then on, I knew I wanted to do research forever. It's a really cool transition from learning all these concepts in books and classes to actually doing an experiment and generating brand new data.

What does a day in your life look like?

One of the things I enjoy about being a grad student is that no two days look the same. I'm a member of the Loh Lab. We use human pluripotent stem cells, which have the potential to develop into any of the body's cell types, to model and better understand early stages of human development.

My research focuses on central nervous system development: I'm trying to establish which signals are instructing cells in the embryo to become all the different types of cells that make up the brain.

In the morning, I come into the lab to do cell culture. In the middle of the day, I have meetings and seminars, and in the afternoons, I do lots of different kinds of assays. That's also generally when I do my outside-of-the-lab activities. I'm on the staff at Queer Student Resources, and on Fridays, I work with the Stanford Prison Education Project.

Tell me more about your advocacy work.

The prison education project is a misnomer, since we currently work only in jails, but Stanford graduate students lead weekly seminars for individuals who are incarcerated at two local correctional centers. The students have different levels of education; some didn't finish high school, while others have advanced professional degrees. The trick is making the lesson fit all those levels. This semester, the theme was virtue and vice. Our role there was not to tell them how to be good or bad people but to discuss how we as a society decide what is virtue and what is vice.

At Queer Student Resources, I'm one of the coordinators for Trans&, a weekly event for transgender folks at Stanford to connect and spend time together. We welcome all students (undergrad, grad and postdoc) and community members who identify with any trans/non-binary/genderqueer identity, or who may be questioning their gender identity.

As a nonbinary scientist, running Trans@ has been a an important way for me to connect with other gender-minority peers at Stanford. Being an advocate is important to me because being a graduate student is already hard enough, and if you're in a disenfranchised or minority group, you can never just be a grad student. At Stanford, people are at least willing to listen to these students' needs, but there's still so much progress that needs to be made, for example when it comes to representation.

Do you have any advice for future graduate students?

First of all, it's important to find your community, whatever that means for you, and to find advocates who are willing to stick out their necks for you. That's easier said than done.

Second, I'd say find something that you love to do that has nothing to do with your work. I do dog-sitting almost every night, and that brings me great joy.

Are you watching or reading anything good lately?

I just finished listening to "Tranny" by Laura Jane Grace, the frontwoman for the pop-punk band "Against Me!" And I've been listening to the storytelling podcast, "The Moth."I like how human it is. After spending all day looking at cells under a microscope, it can be nice to be reminded of the bigger picture.

Photo by Luke Girard/Thru Luke's Lens

Read the original:
In the Spotlight: 'When you're in a minority group, you're never just a grad student' - Scope

Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc. – GlobeNewswire

Selbyville, Delaware, Dec. 05, 2019 (GLOBE NEWSWIRE) --

Global Rat Model Market value is set to surpass USD 1.8 billion by 2025, according to a new research report by Global Market Insights, Inc. Growing usage of rat models in the development of novel vaccines and increase in the adoption of rat models for conducting various research studies on diseases such as autoimmune diseases, cancer, cardiovascular diseases are some of the factors that will majorly drive the rat model industry growth over the projected timeframe.

Rat model is defined as the use of animals to study the development and advancement of diseases since there are various similarities between humans and rats. The upsurge of rat models in biological research studies coupled with functional resemblances of rats to human body are few factors boosting the market growth in the upcoming years. Growing number of animal testing procedures for ensuring drug safety and regular use of rat model in animal testing owing to its genetic similarities with humans are also few factors that are offering significant traction to the market growth. Rats are one of the animals that are widely used in the medical research since they are the primary model for mechanistic studies of human reproduction. Hence, all these factors are expected to boost the adoption of rat models across the globe and is further projected to boost the market growth in the upcoming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4165

On the basis of rat type, the rat model market is segmented as inbred, outbred, knockout, hybrid and others. The inbred rat model business held the maximum share of over 25.0% in 2018. Upsurge of rat models in autoimmune disorder research is rapidly increasing as rat models can mimic autoimmune diseases that affect humans and these models offer a large scale of tissue samples than mice models. These factors further assist researchers to understand the mechanism of diseases that will further play a significant role in propelling the global market growth in the near future.

Some major findings of the rat model market statistics report include:

Based on technology, the rat model market is segmented into CRISPR, microinjection, embryonic stem cell, nuclear transfer and others. The CRISPR technology market accounted for 31.5% market share in 2018. Rapid growth of CRISPR technology is owing to certain advantages such as ease of use, cost-effectiveness, time saving, and greater efficiency required to alter target genes compared to other gene targeting technologies. Hence, the above-mentioned advantages enhance the demand and adoption of CRISPR technology in rat model industry, thereby boosting the business growth.

Browse key industry insights spread across 450 pages with 376 market data tables & 11 figures & charts from the report, Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden, China, Japan, Australia, South Korea, New Zealand, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 2025 in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/rat-model-market

On the basis of application, the market is segment into research & development, production and quality control, academics and others. The research and development segment held the largest revenue share at around 72.2% in the year 2018. The demand of rat models for research and development is in order to check the cognitive function that rats and humans share. Since rats are able to remember wider variety of tasks, it in turn helps the researchers to perform several studies on rats about memory and learning. Hence, such factors are responsible for boosting the rat model market growth for research and development.

On the basis of use, rat model is segmented into human and veterinary. The use of animal model for humans held the highest market share of over 80% in the year 2018. Rise in testing procedures on rats for understanding of diseases such as cardiovascular diseases and diabetes among others that can harm humans is propelling the market growth. Furthermore, increase in the number of rat models for understanding the biological behavior of diseases such as cardiovascular diseases, autoimmune diseases and cancer are few factors that are expected to impel the segmental growth.

On the basis of end-use, rat model industry is segmented into companies, organizations, academic & research institutes and contract research organizations. Companies held the highest market share of over 61.2% in the year 2018. Growing number of research & development activities in the biotech and pharma industry that demands for animal testing for confirming the efficacy and safety of drugs along with the development of novel vaccines are propelling the segmental growth.

The U.S. rat model market is estimated to expand at more than 8.0% CAGR over the projected period. As per the American Burn Association, around 486,000 people were reported at emergency departments for burn/fire injuries. Therefore, various research institutes in the country are conducting physiological tests that rats and humans share in order to mimic the human skin structure. Hence, owing to this, the demand for rat model will significantly escalate in the near future.

Key players are executing several growth strategies such as acquisitions and mergers in order to increase their geographic presence and their product portfolio. For instance, in April 2019, Charles River Laboratories completed the acquisition of Citoxlab. The acquisition would lead to important expansion of the treatment option, thereby resulting in better quality of life. It will further bolster the companys global position by expanding its scientific product portfolio, that will in turn enhance their client partner relations across the drug discovery and development continuum.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4165

Browse Related Reports:

Animal Model Market Analysis Report 2025: On the basis of animal type, the animal model market is segmented as mice, rats, fish, birds, cattle, pigs, amphibians, rabbits, guinea pigs, dogs, cats, sheep, hamsters, monkeys, and others. The mice market held the maximum share of over 51.7% and was valued at around USD 7 billion in the year 2018. The upsurge of mice models in cancer research is burgeoning owing to low-cost factors and widespread availability. Some of the prominent industry players include Charles River, Envigo, genOway, Horizon Discovery Group Plc, Harbour BioMed, Taconic Biosciences, Inc., Janvier Labs, The Jackson Laboratory and TRANS GENIC Inc, Ltd.

https://www.gminsights.com/industry-analysis/animal-model-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Read the original post:
Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc. - GlobeNewswire